Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

110 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Edoxaban for stroke prevention in atrial fibrillation in routine clinical care: 1-year follow-up of the prospective observational ETNA-AF-Europe study.
de Groot JR, Weiss TW, Kelly P, Monteiro P, Deharo JC, de Asmundis C, López-de-Sá E, Waltenberger J, Steffel J, Levy P, Bakhai A, Zierhut W, Laeis P, Manu MC, Reimitz PE, De Caterina R, Kirchhof P. de Groot JR, et al. Among authors: weiss tw. Eur Heart J Cardiovasc Pharmacother. 2021 Apr 9;7(FI1):f30-f39. doi: 10.1093/ehjcvp/pvaa079. Eur Heart J Cardiovasc Pharmacother. 2021. PMID: 32790837 Free article.
Corrigendum to "Uric acid is associated with long-term adverse cardiovascular outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention" [Atherosclerosis 270 (2018) 173-179].
Tscharre M, Herman R, Rohla M, Hauser C, Farhan S, Freynhofer MK, Huber K, Weiss TW. Tscharre M, et al. Among authors: weiss tw. Atherosclerosis. 2020 Aug;306:96. doi: 10.1016/j.atherosclerosis.2020.05.001. Epub 2020 Jul 13. Atherosclerosis. 2020. PMID: 32674806 No abstract available.
Blood pressure changes after renal denervation are more pronounced in women and nondiabetic patients: findings from the Austrian Transcatheter Renal Denervation Registry.
Zweiker D, Lambert T, Steinwender C, Weber T, Suppan M, Brussee H, Niederl E, Koppelstaetter C, Kerschbaum J, Watschinger B, Hohenstein-Scheibenecker K, Reindl-Schwaighofer R, Sturmberger T, Kindslehner C, Weiss TW, Rohla M, Gruener P, Maister P, Auer J, Dechant C, Sykora J, Krismer C, Glaser S, Zirlik A, Zweiker R. Zweiker D, et al. Among authors: weiss tw. J Hypertens. 2019 Nov;37(11):2290-2297. doi: 10.1097/HJH.0000000000002190. J Hypertens. 2019. PMID: 31335512
Characteristics of patients initiated on edoxaban in Europe: baseline data from edoxaban treatment in routine clinical practice for patients with atrial fibrillation (AF) in Europe (ETNA-AF-Europe).
De Caterina R, Kelly P, Monteiro P, Deharo JC, de Asmundis C, López-de-Sá E, Weiss TW, Waltenberger J, Steffel J, de Groot JR, Levy P, Bakhai A, Zierhut W, Laeis P, Kerschnitzki M, Reimitz PE, Kirchhof P; ETNA-AF-Europe investigators. De Caterina R, et al. Among authors: weiss tw. BMC Cardiovasc Disord. 2019 Jul 12;19(1):165. doi: 10.1186/s12872-019-1144-x. BMC Cardiovasc Disord. 2019. PMID: 31299906 Free PMC article.
Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF).
Rohla M, Weiss TW, Pecen L, Patti G, Siller-Matula JM, Schnabel RB, Schilling R, Kotecha D, Lucerna M, Huber K, De Caterina R, Kirchhof P. Rohla M, et al. Among authors: weiss tw. BMJ Open. 2019 Mar 30;9(3):e022478. doi: 10.1136/bmjopen-2018-022478. BMJ Open. 2019. PMID: 30928922 Free PMC article.
110 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page